MI
RIGL icon

Motiv8 Investments’s Rigel Pharmaceuticals RIGL Stock Holding History

Motiv8 Investments’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2 Buy
+50
New +$1.89K ﹤0.01% 774

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Motiv8 Investments's RIGL Position: Q4 2025 in Review

Motiv8 Investments opened a new position in Rigel Pharmaceuticals (RIGL) in Q4 2025: 50 shares worth $2. The stake represents ﹤0.01% of the portfolio and ranks #774 among its holdings.

193 funds tracked by Wall St. Rank hold RIGL as of Q4 2025.

  • Motiv8 Investments held 50 shares of Rigel Pharmaceuticals worth $2 as of Q4 2025.
  • Rigel Pharmaceuticals was a new Motiv8 Investments position in Q4 2025.
  • Rigel Pharmaceuticals made up ﹤0.01% of Motiv8 Investments's portfolio in Q4 2025, its #774 holding.
  • 193 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.